1ST Source Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$466K Sell
1,593
-40
-2% -$13.1K 0.02% 212
2025
Q4
$572K Sell
1,633
-75
-4% -$25.3K 0.03% 183
2025
Q3
$552K Sell
1,708
-120
-7% -$37.3K 0.03% 183
2025
Q2
$711K Sell
1,828
-31
-2% -$12.5K 0.04% 162
2025
Q1
$809K Sell
1,859
-64
-3% -$25.7K 0.05% 148
2024
Q4
$709K Sell
1,923
-53
-3% -$22.2K 0.04% 159
2024
Q3
$1.03M Sell
1,976
-110
-5% -$58.8K 0.06% 129
2024
Q2
$1.13M Buy
2,086
+81
+4% +$42.8K 0.07% 121
2024
Q1
$1.04M Sell
2,005
-217
-10% -$108K 0.06% 134
2023
Q4
$1.05M Sell
2,222
-73
-3% -$33.8K 0.06% 127
2023
Q3
$999K Sell
2,295
-38
-2% -$17.2K 0.07% 124
2023
Q2
$1.04M Sell
2,333
-16
-0.7% -$7.38K 0.07% 127
2023
Q1
$1.08M Sell
2,349
-78
-3% -$37.1K 0.07% 123
2022
Q4
$1.24M Hold
2,427
0.08% 115
2022
Q3
$1.1M Buy
2,427
+54
+2% +$25.8K 0.08% 117
2022
Q2
$1.15M Buy
2,373
+11
+0.5% +$5.44K 0.08% 123
2022
Q1
$1.16M Sell
2,362
-15
-0.6% -$6.86K 0.07% 128
2021
Q4
$1.1M Buy
2,377
+10
+0.4% +$4.21K 0.06% 131
2021
Q3
$882K Hold
2,367
0.06% 141
2021
Q2
$904K Buy
2,367
+93
+4% +$35.5K 0.06% 142
2021
Q1
$816K Sell
2,274
-2,370
-51% -$762K 0.05% 142
2020
Q4
$1.49M Buy
4,644
+2,364
+104% +$725K 0.11% 104
2020
Q3
$613K Buy
2,280
+270
+13% +$72.6K 0.05% 143
2020
Q2
$528K Sell
2,010
-163
-8% -$43.5K 0.05% 152
2020
Q1
$494K Buy
2,173
+62
+3% +$16.9K 0.05% 144
2019
Q4
$637K Sell
2,111
-134
-6% -$36.9K 0.05% 146
2019
Q3
$539K Buy
2,245
+1
+0% +$274 0.04% 150
2019
Q2
$633K Sell
2,244
-56
-2% -$15.3K 0.05% 140
2019
Q1
$660K Sell
2,300
-123
-5% -$35.6K 0.06% 132
2018
Q4
$636K Buy
2,423
+214
+10% +$58.8K 0.06% 124
2018
Q3
$605K Sell
2,209
-115
-5% -$29.9K 0.05% 144
2018
Q2
$553K Sell
2,324
-108
-4% -$25K 0.04% 146
2018
Q1
$534K Buy
2,432
+299
+14% +$70.2K 0.04% 148
2017
Q4
$480K Sell
2,133
-959
-31% -$204K 0.04% 151
2017
Q3
$587K Sell
3,092
-192
-6% -$36.5K 0.05% 142
2017
Q2
$618K Sell
3,284
-250
-7% -$44.9K 0.05% 142
2017
Q1
$584K Sell
3,534
-260
-7% -$41.4K 0.05% 145
2016
Q4
$545K Buy
3,794
+123
+3% +$16.5K 0.05% 143
2016
Q3
$460K Buy
3,671
+24
+0.7% +$3.1K 0.05% 160
2016
Q2
$479K Buy
3,647
+175
+5% +$23.9K 0.05% 155
2016
Q1
$483K Sell
3,472
-840
-19% -$112K 0.05% 153
2015
Q4
$601K Buy
4,312
+188
+5% +$25.9K 0.07% 139
2015
Q3
$577K Sell
4,124
-115
-3% -$17.3K 0.07% 165
2015
Q2
$695K Sell
4,239
-439
-9% -$70.1K 0.08% 140
2015
Q1
$722K Buy
4,678
+760
+19% +$108K 0.09% 129
2014
Q4
$492K Sell
3,918
-12
-0.3% -$1.48K 0.06% 148
2014
Q3
$470K Sell
3,930
-180
-4% -$20.6K 0.06% 146
2014
Q2
$442K Hold
4,110
0.06% 149
2014
Q1
$410K Sell
4,110
-1,000
-20% -$90.4K 0.05% 151
2013
Q4
$472K Sell
5,110
-1,855
-27% -$165K 0.06% 146
2013
Q3
$582K Sell
6,965
-270
-4% -$23.1K 0.09% 137
2013
Q2
$592K Buy
+7,235
New +$541K 0.1% 117

Other funds holding ELV

1ST Source Bank's ELV Position: Q1 2026 in Review

1ST Source Bank reduced its Elevance Health (ELV) stake by 2.4% in Q1 2026, selling an estimated $13.1K and leaving 1,593 shares worth $466K. The position accounts for 0.02% of the portfolio, ranked #212.

1ST Source Bank first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.49M in Q4 2020. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • 1ST Source Bank held 1,593 shares of Elevance Health worth $466K as of Q1 2026.
  • 1ST Source Bank sold 40 Elevance Health shares in Q1 2026, an estimated $13.1K.
  • Elevance Health made up 0.02% of 1ST Source Bank's portfolio in Q1 2026, its #212 holding.
  • 1ST Source Bank first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • 1ST Source Bank's Elevance Health position peaked at $1.49M in Q4 2020.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on 1ST Source Bank's 13F filing for Q1 2026, filed 4 May 2026.